Package 31722-871-30

Brand: buprenorphine hcl

Generic: buprenorphine hcl
NDC Package

Package Facts

Identity

Package NDC 31722-871-30
Digits Only 3172287130
Product NDC 31722-871
Product ID 31722-871_80bd7b21-6679-4dbb-84dd-f755c7a90166
Description

30 TABLET in 1 BOTTLE (31722-871-30)

Marketing

Marketing Status
Marketed Since 2026-01-12
Brand buprenorphine hcl
Generic buprenorphine hcl
Sample Package No

Linked Drug Pages (1)

Buprenorphine HCl ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "80bd7b21-6679-4dbb-84dd-f755c7a90166", "openfda": {"upc": ["0331722871303", "0331722870306"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["b52cea0e-688f-4beb-bf7d-f228b81dbd23"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-871-30)", "package_ndc": "31722-871-30", "marketing_start_date": "20260112"}], "brand_name": "Buprenorphine HCl", "product_id": "31722-871_80bd7b21-6679-4dbb-84dd-f755c7a90166", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "31722-871", "dea_schedule": "CIII", "generic_name": "Buprenorphine HCl", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA219401", "marketing_category": "ANDA", "marketing_start_date": "20260112", "listing_expiration_date": "20271231"}